![Martin Steiner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin Steiner
Vorstandsvorsitzender bei
SYNIMMUNE GmbH
Profil
Martin Steiner is the founder of ImVisioN Therapeutics AG, which was founded in 2008.
He held the position of Director, Chief Executive & Financial Officer from 2011 to 2014.
Dr. Steiner is currently the President, Secretary, Treasurer & Director at ImVision Therapeutics, Inc. and Co-Managing Director at SYNIMMUNE GmbH since 2016.
In the past, he was the Chief Executive Officer at Apovia AG from 1997 to 2004 and Director-Business Development at Smithkline Beecham Biologicals Immunotherapeutics in 1997.
Dr. Steiner was also the Chief Executive & Financial Officer at ImVisioN GmbH.
Dr. Steiner holds an MBA from the University of Michigan and a doctorate from the University of Vienna.
Aktive Positionen von Martin Steiner
| Unternehmen | Position | Beginn |
|---|---|---|
ImVision Therapeutics, Inc.
 ImVision Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops proprietary technology for the delivery of immunotherapeutics in the treatment of allergies | Präsident | - |
SYNIMMUNE GmbH
 SYNIMMUNE GmbH Miscellaneous Commercial ServicesCommercial Services Operates as a bio technology company that develops antibodies | Vorstandsvorsitzender | 01.03.2016 |
Ehemalige bekannte Positionen von Martin Steiner
| Unternehmen | Position | Ende |
|---|---|---|
ImVisioN Therapeutics AG
 ImVisioN Therapeutics AG Miscellaneous Commercial ServicesCommercial Services Operates as a holding company with interest in providing immunotherapy | Vorstandsvorsitzender | 13.02.2014 |
Apovia AG | Präsident | 01.01.2004 |
Smithkline Beecham Biologicals Immunotherapeutics | Corporate Officer/Principal | 01.01.1997 |
ImVisioN GmbH
 ImVisioN GmbH Miscellaneous Commercial ServicesCommercial Services Provides research in intralymphatic immunotherapy | Vorstandsvorsitzender | - |
Ausbildung von Martin Steiner
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
6
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
ImVision Therapeutics, Inc.
ImVision Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops proprietary technology for the delivery of immunotherapeutics in the treatment of allergies | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Vienna
 University of Vienna Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImVisioN GmbH
ImVisioN GmbH Miscellaneous Commercial ServicesCommercial Services Provides research in intralymphatic immunotherapy | Commercial Services |
Apovia AG | |
ImVisioN Therapeutics AG
ImVisioN Therapeutics AG Miscellaneous Commercial ServicesCommercial Services Operates as a holding company with interest in providing immunotherapy | Commercial Services |
Smithkline Beecham Biologicals Immunotherapeutics | |
SYNIMMUNE GmbH
SYNIMMUNE GmbH Miscellaneous Commercial ServicesCommercial Services Operates as a bio technology company that develops antibodies | Commercial Services |
